Search references for NMRA 511. Phrases containing NMRA 511
See searches and references containing NMRA 511!NMRA 511
Pharmaceutical compound
NMRA-511, also known as BTRX-323511 or NMRA-323511, is a vasopressin V1A receptor antagonist which is under development for the treatment of agitation
NMRA-511
Peptide hormone and neuropeptide
oxytocin and neurophysin in the human thymus". Science. 232 (4749): 508–511. Bibcode:1986Sci...232..508G. doi:10.1126/science.3961493. hdl:2268/16909
Oxytocin
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Tolvaptan
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
LIT-002
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Lithium_carbonate
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin_(medication)
Medication
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Desmopressin
Medication made from the peptide oxytocin
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Oxytocin_(medication)
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Demeclocycline
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Barusiban
Medication causing uterine contraction
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Uterotonic
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
TGOT
Mammalian hormone released from the pituitary gland
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Retosiban
Dexmedetomidine sublingual (iXB-120) – α2-adrenergic receptor agonist NMRA-511 (BTRX-323511; NMRA-323511) – vasopressin V1A receptor antagonist SEP-380135 – undefined
List of investigational agitation drugs
List_of_investigational_agitation_drugs
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Relcovaptan
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
SRX251
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Brezivaptan
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasotocin
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Atosiban
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Balovaptan
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Lixivaptan
Medication used for preventing postpartum bleeding
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Carbetocin
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Cligosiban
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Terlipressin
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Oxytocin_receptor_agonist
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Conivaptan
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Nelivaptan
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
PF-06655075
Oxytocin receptor antagonist
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Tocinoic_acid
Cleavage product of the arginine vasopressin gene
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Neurophysin_II
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
NP-1031
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
L-368,899
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
NTX-1472
Genes on human chromosome 3
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Oxytocin_receptor
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
PF-184563
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Demoxytocin
Carrier protein for oxytocin and vasopressin
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Neurophysins
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Felypressin
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Nolasiban
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Mozavaptan
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
CA7_(drug)
Vasopressin V1A receptor antagonist
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
RG7713
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
KNX-100
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
KNX-101
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Ornipressin
Cleavage product of the coding protein of OXT gene
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Neurophysin_I
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Epelsiban
Protein-coding gene in the species Homo sapiens
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin_receptor_1A
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
TC_OT_39
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
SRX246
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Lipo-oxytocin-1
G protein-coupled receptor
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin_receptor
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
WAY-267464
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Selepressin
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
ABT-436
Agent that interferes with action at the vasopressin receptors
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin receptor antagonist
Vasopressin_receptor_antagonist
Investigational anxiety disorder drugs
actions [38] LY-293284 – serotonin 5-HT1A receptor agonist [39] NMRA-511 (BTRX-323511; NMRA-323511) – vasopressin V1A receptor antagonist [40] Paroxetine
List of investigational anxiety disorder drugs
List_of_investigational_anxiety_disorder_drugs
Protein-coding gene in the species Homo sapiens
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin_receptor_1B
Small-molecule oxytocin receptor agonist
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
LIT-001
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
WJ0679
Pharmaceutical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
OT-12
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
L-371,257
Protein-coding gene in the species Homo sapiens
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Vasopressin_receptor_2
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Satavaptan
Chemical compound
Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT
Merotocin
use in various neuropsychological disorders. One representative molecule NMRA-511 is currently in phase 2 clinical trials. Novel compounds for use in fibrotic
Edward_Roberts_(chemist)
travel, tourism, insurance
NMRA 511
NMRA 511
Girl/Female
Hebrew
Plow.
Girl/Female
Indian
Soft, Lion
Girl/Female
Muslim
Delicious water
Female
English
 English form of Irish Nóra, NORA means "honor, valor." Compare with another form of Nora.
Girl/Female
American, Arabic, Christian, Farsi, Greek, Irish, Latin, Muslim, Swedish
Light; Honour
Girl/Female
Indian
Princess
Girl/Female
Muslim
Princess
Girl/Female
Hindu, Indian, Modern
Beauty of Goddess Saraswati
Boy/Male
Hindu
Love
Girl/Female
Muslim
Light, Illuminate
Girl/Female
American, British, English, Japanese, Latin
Happy; Near One; Joyous; Place Name; The Nearest and Dearest One; An Oak Tree; A Companion
Boy/Male
Gujarati, Indian
Kind; Soft; Flexible
Girl/Female
Irish American Greek Hebrew Latin English French Italian
Girl/Female
Muslim
Soft, Lion
Girl/Female
Hindu
Amrit or nectar or pure water, Part of God
Girl/Female
Indian
Delicious water
Girl/Female
Indian
Light, Illuminate
Girl/Female
Hindu
Light
Girl/Female
Arabic Muslim
Light.
Girl/Female
Gaelic Celtic English Native American
Happy.
NMRA 511
NMRA 511
NMRA 511
NMRA 511
NMRA 511
NMRA 511
NMRA 511
travel, tourism, insurance